Thermo Fisher Scientific Inc.
TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3025% above fair value
$682.65−14.35 (-2.06%)
Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%
Thermo Fisher Scientific North America Revenue: $6,149M in Q2 2026, up 7.5% from a year earlier.
Latest, Q2 2026
6,149
Period ended Jun 30, 2026
Change on a year earlier
+7.5%
5,722 in Q2 2025
History
28 quarters
Since Q3 2019
Sources
23
Documents cited below
Where the Q2 2026 figure comes from
“|| North America | $ | 6,149 | $ | 5,722 | $ | 11,854 | $ | 11,235”
Source: SEC Form 10-Q (10q_2026Q2, filed 2026-07-31) ↗
Q4 derived from full year (10-K) minus 9 months (10-Q).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up north America Revenue
Cite this data
StockData. (2026). Thermo Fisher Scientific North America Revenue ($M), quarterly Q3 2019–Q2 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/rev-geo-north-america
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.